Arivalagan Muthusamy

Chief Scientist

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Arivalagan Muthusamy is a Chief Scientist at the Zietchick Research Institute in the United States. His research primarily focuses on thrombolytic therapies, inflammatory resolution, and the vascular barriers related to ischemic injuries and retinopathy of prematurity. Recent articles highlight the interplay between various biomarkers and conditions affecting preterm infants.

Articles (6)

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Manuel Zeitelhofer

Associate Professor / Docent

Karolinska Institutet

SWEDEN

View details

Steven F Abcouwer

Associate Professor

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arivalagan Muthusamy

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin.

Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury

Associations between VEGF isoforms and impending retinopathy of prematurity

Feasibility of neonatal haemoglobin A1C as a biomarker for retinopathy of prematurity

The association between high levels of luteinizing hormone and proliferative retinopathy of prematurity in female preterm infants

The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity

Collaborators (2)

Manuel Zeitelhofer

Steven F Abcouwer

Make your next move.